相关实验视频
Updated: Jun 9, 2026

09:17
Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
长期COVID中状结质变化及其与阿尔茨海默氏病相关的风险
Huize Pang1, Jennifer Frontera2, Li Jiang1
1Department of Radiology, NYU Grossman School of Medicine, New York, New York, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|January 30, 2026
概括
长期COVID患者表现出胆管扩大和脑血流减少,这可能表明神经炎症. 这些变化与阿尔茨海默氏症生物标志物和认知衰退相关,表明ChP变化是关键指标.
科学领域:
- 神经成像是一种神经成像.
- 神经学 神经学
- 传染性疾病 传染性疾病
背景情况:
- 冠状腺 (ChP) 扩大是一种已知的神经成像生物标志物,用于神经炎症和神经退行.
- 关于长期COVID中ChP结构和 perfusion 变化及其临床意义的证据有限.
研究的目的:
- 在长期的COVID患者中调查胆 (ChP) 体积和脑血流 (CBF).
- 检查CHP变化与阿尔茨海默病 (AD) 症状和血生物标志物之间的关联.
主要方法:
- 包括86例长期COVID,67例康复COVID和26例健康对照 (HC).
- 使用神经成像技术量化CHP体积和CBF.
- 评估了与AD症状和血生物标志物的相关性.
主要成果:
- 与HC相比,长期COVID和康复的COVID组都显示了CHP体积的增加和CBF的减少.
- 长期COVID患者的CHP体积明显大于康复的COVID患者.
- P体积和CBF与AD生物标志物 (例如,p-tau217) 和认知衰退相关.
结论:
- 长期COVID中状变化与阿尔茨海默病相关的认知衰退和高血生物标志物有关.
- 在COVID后的条件下,ChP变化可以作为神经症状和AD病理的成像标记物.
相关概念视频
Long-term Depression
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...
Calcium Ion Concentration Mechanism
If over time, all...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Increased Intracranial Pressure ll: Pathophysiology
Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...

